SOPHiA GENETICS SA (SOPH) Earnings Call Analysis

NASDAQ · Healthcare · Health Information Services

20/25

Growth 5 Margin 2 Expansion 5 Platform 5 Financial 3

latest quarter score

Earnings Reports

20
Sophia Genetics (SOPH) Q2 2026: U.S. Revenue Soars 64% as Platform Expansion Drives Global Scale
August 04, 2026
23
SOPH Q1 2026: Net Dollar Retention Climbs to 117% as Platform Expansion Drives Upsell Momentum
May 05, 2026
23
Sophia Genetics (SOPH) Q4 2025: 31% Clinical Revenue Surge Signals Platform Expansion
March 03, 2026
22
Sophia Genetics (SOPH) Q3 2025: 180% Jump in Large Deal Value Signals Pipeline Inflection
November 04, 2025
23
Sophia Genetics (SOPH) Q2 2025: 35 New Customers Drive 20% Core Clinical Growth, Biopharma Stabilizes
August 05, 2025
23
Sophia Genetics (SOPH) Q1 2025: Adjusted Gross Margin Soars 520 bps as Platform Scale Accelerates
July 07, 2025
SOPHiA GENETICS (SOPH) Q4 2024: 13% Clinical Volume Growth Sets Stage for 2025 Reacceleration
March 04, 2025

Browse all companies